New Zealand raises concerns with Elanco/Bayer

New Zealand’s competition watchdog is concerned that Elanco Animal Health’s €7 billion acquisition of Bayer’s animal health business could harm competition for the wholesale supply of several animal healthcare products.


Get unlimited access to all Global Competition Review content